{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:51:39Z","timestamp":1767135099688,"version":"build-2238731810"},"reference-count":72,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012342","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T11:22:46Z","timestamp":1472815366000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders"],"prefix":"10.1002","author":[{"given":"Asma","family":"Ashraf","sequence":"first","affiliation":[{"name":"Calvary Mater Hospital; University of Newcastle; Haematology; Crn Edith street & Platt street Level 4 New Medical building Waratah NSW Australia 2298"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas V","family":"Hadjinicolaou","sequence":"additional","affiliation":[{"name":"University of Oxford; Human Immunology Unit, Institute of Molecular Medicine, Radcliffe Department of Medicine; Merton College, Merton Street Oxford UK OX1 4JD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Doree","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; John Radcliffe Hospital Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Hopewell","sequence":"additional","affiliation":[{"name":"University of Oxford; Oxford Clinical Trials Research Unit; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences Windmill Road Oxford Oxfordshire UK OX3 7LD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialena","family":"Trivella","sequence":"additional","affiliation":[{"name":"University of Oxford; Centre for Statistics in Medicine; Botnar Research Centre Windmill Road Oxford UK OX3 7LD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise J","family":"Estcourt","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Haematology\/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"10.1002\/14651858.CD012342-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V81.6.1411.1411","article-title":"Platelet transfusions: the 20,000\/\u03bcL trigger","volume":"81","author":"Beutler","year":"1993","journal-title":"Blood"},{"key":"10.1002\/14651858.CD012342-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Blumberg N Heal JM Phillips GL Platelet transfusions: trigger, dose, benefits, and risks F1000 Medical Reports 2010","DOI":"10.3410\/M2-5"},{"issue":"1","key":"10.1002\/14651858.CD012342-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1179\/acb.2007.006","article-title":"Guidelines for transfusion of platelets","volume":"62","author":"Bosly","year":"2007","journal-title":"Acta Clinica Belgica:International Journal of Clinical and Laboratory Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012342-BIB0004|cit4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010981.pub2","article-title":"A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation","author":"Crighton","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012342-BIB0005|cit5","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD012342-BIB0006|cit6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012055","article-title":"Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review","author":"Desborough","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012342-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ejca.2013.12.002","article-title":"Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010","volume":"50","author":"Dinmohamed","year":"2014","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD012342-BIB0008|cit8","unstructured":"Effective Practice Organisation of Care (EPOC) EPOC Resources for review authors Oslo: Norwegian Knowledge Centre for the Health Services 2015. Available at: http:\/\/epoc.cochrane.org\/epoc-specific-resources-review-authors"},{"issue":"7","key":"10.1002\/14651858.CD012342-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/trf.12058","article-title":"The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions","volume":"53","author":"Estcourt","year":"2013","journal-title":"Transfusion"},{"issue":"11","key":"10.1002\/14651858.CD012342-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010983.pub2","article-title":"Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation","author":"Estcourt","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012342-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients?","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfusion Medicine Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012342-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1537-2995.2010.03039.x","article-title":"A comprehensive program to minimize platelet outdating","volume":"51","author":"Fuller","year":"2011","journal-title":"Transfusion"},{"issue":"7","key":"10.1002\/14651858.CD012342-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ajh.23264","article-title":"Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management","volume":"87","author":"Garcia-Manero","year":"2012","journal-title":"American Journal of Hematology"},{"issue":"18","key":"10.1002\/14651858.CD012342-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM196205032661802","article-title":"The quantitative relation between platelet count and haemorrhage in patients with acute leukaemia","volume":"266","author":"Gaydos","year":"1962","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012342-BIB0015|cit15","unstructured":"Executive Committee of the German Medical Association on the recommendation of the Scientific Advisory Board Cross-sectional guidelines for therapy with blood components and plasma derivatives http:\/\/www.bundesaerztekammer.de\/aerzte\/medizin-ethik\/wissenschaftlicher-beirat\/veroeffentlichungen\/haemotherapie-transfusionsmedizin\/english\/"},{"issue":"2","key":"10.1002\/14651858.CD012342-BIB0016|cit16","first-page":"57","article-title":"The inherited bone marrow failure syndromes","volume":"8","author":"Giri","year":"2004","journal-title":"Haematologia"},{"issue":"8777","key":"10.1002\/14651858.CD012342-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0140-6736(91)92098-M","article-title":"Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia","volume":"338","author":"Gmur","year":"1991","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012342-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2141.2003.04153.x","article-title":"A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin and granulocyte colony-stimulating factor: significant effects on quality of life","volume":"120","author":"Hellstr\u00f6m-Lindberg","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD012342-BIB0019|cit19","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD012342-BIB0020|cit20","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD012342-BIB0021|cit21","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in Statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD012342-BIB0022|cit22","unstructured":"Higgins JPT Deeks JJ Altman DG on behalf of the Cochrane Statistical Methods Group (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD012342-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","article-title":"Platelet transfusion refractoriness","volume":"42","author":"Hod","year":"2008","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD012342-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1299-1307","DOI":"10.1182\/blood-2005-01-0161","article-title":"The epidemiology of aplastic anaemia in Thailand","volume":"107","author":"Issaragrisil","year":"2006","journal-title":"Blood"},{"key":"10.1002\/14651858.CD012342-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012342-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/bjh.12694","article-title":"Guidelines for the diagnosis and management of adult myelodysplastic syndromes","volume":"164","author":"Killick","year":"2014","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1002\/14651858.CD012342-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"British Journal of Haematology"},{"issue":"7568","key":"10.1002\/14651858.CD012342-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD012342-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1200\/JCO.2006.05.9048","article-title":"Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukaemia and myelodysplastic syndrome after breast cancer","volume":"25","author":"Deley","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012342-BIB0030|cit30","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD012342-BIB0031|cit31","first-page":"132","article-title":"Recommendations for the transfusion of plasma and platelets","volume":"7","author":"Liumbruno","year":"2009","journal-title":"Blood Transfusion"},{"issue":"8","key":"10.1002\/14651858.CD012342-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/cncr.22570","article-title":"Myelodysplastic syndromes: incidence and survival in the United States","volume":"109","author":"Ma","year":"2007","journal-title":"Cancer"},{"issue":"7","key":"10.1002\/14651858.CD012342-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2012.04.014","article-title":"Epidemiology of myelodysplastic syndromes","volume":"125","author":"Ma","year":"2012","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012342-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic reviews and Meta-Analyses:The PRISMA Statement","volume":"151","author":"Moher","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012342-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3324\/haematol.12020","article-title":"Epidemiology of aplastic anaemia: A prospective multicenter study","volume":"93","author":"Montan\u00e9","year":"2008","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD012342-BIB0036|cit36","unstructured":"National Blood Authority Patient blood management guideline The National Blood Authority\u2019s Patient Blood Management Guideline: Module 3 - Medical. 2012"},{"issue":"12","key":"10.1002\/14651858.CD012342-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.leukres.2011.06.001","article-title":"Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS-registry","volume":"35","author":"Neukirchen","year":"2011","journal-title":"Leukemia Research"},{"key":"10.1002\/14651858.CD012342-BIB0038|cit38","unstructured":"National Institute for Health and Clinical Excellence Blood transfusion NG24 www.nice.org.uk\/guidance\/ng24 2015"},{"issue":"24","key":"10.1002\/14651858.CD012342-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD012342-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1743-422X-8-87","article-title":"Hepatitis associated aplastic anemia: a review","volume":"28","author":"Rauff","year":"2011","journal-title":"Virology Journal"},{"issue":"4","key":"10.1002\/14651858.CD012342-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/vox.12234","article-title":"Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion","volume":"108","author":"Raval","year":"2015","journal-title":"Vox Sanguinis"},{"issue":"26","key":"10.1002\/14651858.CD012342-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukaemia","volume":"337","author":"Rebulla","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012342-BIB0043|cit43","unstructured":"Reeves BC Deeks JJ Higgins JPT Wells GA Chapter 13: Including non-randomised studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD012342-BIB0044|cit44","unstructured":"The Nordic Cochrane Centre. The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"9","key":"10.1002\/14651858.CD012342-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1537-2995.2011.03539.x","article-title":"Using lean techniques to define the platelet (PLT) transfusion process and cost-effectiveness to evaluate PLT dose transfusion strategies","volume":"52","author":"Riley","year":"2012","journal-title":"Transfusion"},{"issue":"1","key":"10.1002\/14651858.CD012342-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1182\/blood-2008-01-134858","article-title":"Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs","volume":"112","author":"Rollison","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1002\/14651858.CD012342-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V93.9.3124","article-title":"A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anaemia","volume":"93","author":"Sagmeister","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD012342-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology*","volume":"19","author":"Schiffer","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD012342-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrclinonc.2013.113","article-title":"Haematological cancer: Prophylactic platelet transfusion is frequently not necessary","volume":"10","author":"Schiffer","year":"2013","journal-title":"Nature Review Clinical Oncology"},{"key":"10.1002\/14651858.CD012342-BIB0050|cit50","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD012342-BIB0051|cit51","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD012342-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.hoc.2010.02.011","article-title":"The epidemiology of myelodysplastic syndromes","volume":"24","author":"Sekeres","year":"2010","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"1","key":"10.1002\/14651858.CD012342-BIB0053|cit53","first-page":"329","article-title":"Clinical approach to marrow failure","volume":"2009","author":"Shimamura","year":"2009","journal-title":"ASH Education Program Book"},{"issue":"3","key":"10.1002\/14651858.CD012342-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0308-2261(21)00047-3","article-title":"Thrombocytopenia: mechanisms and management of defects in platelet production","volume":"7","author":"Slichter","year":"1978","journal-title":"Clinics in Haematology"},{"issue":"3","key":"10.1002\/14651858.CD012342-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","article-title":"Relationship between platelet count and bleeding risk in thrombocytopenic patients","volume":"18","author":"Slichter","year":"2004","journal-title":"Transfusion Medicine Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012342-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1002\/14651858.CD012342-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of haemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD012342-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD012342-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/trf.12646","article-title":"Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomised trial","volume":"54","author":"Stanworth","year":"2014","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD012342-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness-practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD012342-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4065\/81.1.104","article-title":"The myelodysplastic syndromes: diagnosis and treatment","volume":"81","author":"Steensma","year":"2006","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD012342-BIB0062|cit62","unstructured":"Sterne JAC Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD012342-BIB0063|cit63","unstructured":"Sterne JAC Higgins JPT Reeves BC on behalf of the development group for ACROBAT- NRSI A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBAT- NRSI), Version 1.0.0 http:\/\/www.riskofbias.info"},{"key":"10.1002\/14651858.CD012342-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Tierney JF Stewart LA Ghersi D Burdett S Sydes MR Practical methods for incorporating summary time-to-event data into meta-analysis Trials 2007 10.1186\/1745-6215-8-16","DOI":"10.1186\/1745-6215-8-16"},{"issue":"2","key":"10.1002\/14651858.CD012342-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/bjh.12017","article-title":"Guideline on the investigation and management of acute transfusion reactions","volume":"159","author":"Tinegate","year":"2012","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD012342-BIB0066|cit66","article-title":"Chapter 18: Platelet transfusion, alloimmunization and management of platelet refractoriness","volume-title":"Canadian Blood Services","author":"Tinmouth","year":"2007"},{"issue":"26","key":"10.1002\/14651858.CD012342-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","author":"The Trial to Reduce Alloimmunization to Platelets Study Group","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012342-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.transci.2009.07.005","article-title":"Platelet utilization in the developing world: strategies to optimise platelet transfusion practices","volume":"41","author":"Verma","year":"2009","journal-title":"Transfusion and Apheresis Science"},{"issue":"10","key":"10.1002\/14651858.CD012342-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V91.10.3601","article-title":"Safety and cost effectiveness of a 10x109\/L trigger for prophylactic platelet transfusions compared with the traditional 20x109\/L trigger: A prospective comparative trial in 105 patients with acute myeloid leukaemia","volume":"91","author":"Wandt","year":"1998","journal-title":"Blood"},{"issue":"9850","key":"10.1002\/14651858.CD012342-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multi centre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012342-BIB0071|cit71","volume-title":"WHO Handbook for Reporting Results of Cancer Treatment","author":"World Health Organization","year":"1979"},{"issue":"4","key":"10.1002\/14651858.CD012342-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.12855","article-title":"The epidemiology of acquired aplastic anaemia","volume":"93","author":"Young","year":"2008","journal-title":"Haematologica"}],"updated-by":[{"DOI":"10.1002\/14651858.cd012342.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T12:45:51Z","timestamp":1657197951000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012342"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":72,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012342","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]}}}